Abstract |
A sensitive and specific radioimmunoassay (RIA) for human embryonic zeta-globin chains was used to study normal fetal blood and newborn cord blood as well as cord blood from newborns with alpha-thalassemias. From 17 weeks until 37 weeks of gestation, zeta-globin chains were present in almost all fetal and cord blood samples (0.27% +/- 0.15% in samples of weeks 17 through 30; 0.14% +/- 0.11% in samples of weeks 31 through 37). zeta-Globin chains were present in greater than 80% of cord blood hemolysates from normal, full-term newborns (0.15% +/- 0.11%) as well as from 16 near-term newborns of diabetic mothers (0.13% +/- 0.13%). zeta-Globin chains were not detected in normal infants aged 3 months to 2 years. In cord blood hemolysates from alpha-thalassemic newborns, the levels of zeta-globin chain content varied from very high to undetectable levels. Gene mapping of the zeta- alpha-globin gene cluster was performed in 12 newborns in whom cord blood zeta-globin chains had been determined. Newborns who were carriers of alpha-thalassemia-1 due to the (--SEA/) deletion had very high levels of zeta-globin chains (greater than 1.5%).
|
Authors | D H Chui, W C Mentzer, M Patterson, T A Iarocci, S H Embury, S P Perrine, R S Mibashan, D R Higgs |
Journal | Blood
(Blood)
Vol. 74
Issue 4
Pg. 1409-14
(Sep 1989)
ISSN: 0006-4971 [Print] United States |
PMID | 2475189
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Hemoglobins, Abnormal
- Globins
- Fetal Hemoglobin
- hemoglobin Bart's
|
Topics |
- Aging
- Diabetes Mellitus
(blood, genetics)
- Embryonic and Fetal Development
- Fetal Blood
(analysis)
- Fetal Hemoglobin
(analysis, genetics, physiology)
- Genotype
- Globins
(analysis, genetics, physiology)
- Hemoglobins, Abnormal
(analysis)
- Humans
- Infant, Newborn
|